OpenAI is investing in Merge Labs, a research facility focused on brain-computer interfaces (BCIs). These interfaces aim to improve how people communicate and interact with technology by enhancing the connection between human intent and devices. Merge Labs seeks to create safer, high-bandwidth BCIs that integrate biology, AI, and devices. This investment is seen as a way to advance the development of technology that can profoundly impact human capability and agency. The team behind Merge Labs includes researchers Mikhail Shapiro, Tyson Aflalo, and Sumner Norman, who have developed novel BCI approaches. They are joined by entrepreneurs like Alex Blania, Sandro Herbig, and Sam Altman, who are backing the project personally. OpenAI plans to collaborate with Merge Labs on foundational scientific models and tools, leveraging AI to accelerate research in fields like bioengineering and neuroscience. The investment reflects OpenAI's commitment to pushing the boundaries of technology that enhances human experience. By focusing on high-bandwidth interfaces, Merge Labs aims to create systems that can interpret user intent and adapt effectively, even in challenging conditions. The collaboration promises to bring together advanced research and practical applications, potentially leading to transformative products in the future.